Bill > A04367

This bill makes several technical changes to New York's cannabis law regarding cannabinoid hemp retail sales and product labeling. It narrows the definition of THC to specifically mean Delta-9-tetrahydrocannabinol, removing references to other THC isomers, and redefines "Total THC" as the dry weight percentage of Delta-9-THC in a product. The bill establishes new labeling requirements for hemp-derived cannabinoid products, mandating that they include a nutrition label with serving size, a warning that the product is not FDA-regulated and cannot treat medical conditions, the amount of hemp-derived product per serving in milligrams, and the manufacturer's address. Additionally, the bill clarifies that cannabinoid hemp flower products intended for smoking can only be sold to individuals 21 years and older, and gives the cannabis board authority to regulate these products without infringing on licensed retailers' operations. These changes aim to provide more clarity and consumer protection in the cannabinoid hemp product market by standardizing product information and sales restrictions.

Business and Industry

https://www.nysenate.gov/legislation/bills/2025/A4367